MDNA-209

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameMDNA-209
Drug Alias NameMDNA-209
ClassificationBiologics
Mechanisms of ActionInterleukin-2 receptor beta chain inhibitors
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A